Theriva Biologics (TOVX) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.21, -1.00% vs the prior close of $0.21.
- Volume 218.00K shares, 0.4x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
TOVX dips 1.0% to $0.21, a 6-month low, 7 down days in a row. Closed at $0.21, -1.00% vs the prior close of $0.21. Day range $0.21–$0.22, opened at $0.22.
TOVX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — TOVX dips 1.0% to $0.21, a 6-month low, 7 down days in a row
- Closed at $0.21, -1.00% vs the prior close of $0.21. Day range $0.21–$0.22, opened at $0.22.
- Volume was 218.00K shares, 0.4x its 50-day average of 527.47K — lighter than usual.
- Price is -10.7% vs its 50-day average ($0.23) and -13.8% vs its 200-day average ($0.24).
- 52-week range $0.16–$0.85; today's close sits at 7% of that range, 75.5% below the 52-week high.
- That makes 7 straight losses.
Oct 15, 2026 — TOVX ends flat (+0.0%) to $0.21, 6 down days in a row
- Closed at $0.21, +0.00% vs the prior close of $0.21. Day range $0.21–$0.22, opened at $0.21.
- Volume was 363.70K shares, 0.7x its 50-day average of 524.43K.
- Price is -9.9% vs its 50-day average ($0.23) and -12.9% vs its 200-day average ($0.24).
- 52-week range $0.16–$0.86; today's close sits at 7% of that range, 75.6% below the 52-week high.
- That makes 6 straight losses.
Oct 14, 2026 — TOVX slides 4.5% to $0.21, 5 down days in a row
- Closed at $0.21, -4.55% vs the prior close of $0.22. Day range $0.21–$0.22, opened at $0.22.
- Volume was 382.00K shares, 0.7x its 50-day average of 531.31K.
- Price is -10.0% vs its 50-day average ($0.23) and -12.9% vs its 200-day average ($0.24).
- 52-week range $0.16–$0.86; today's close sits at 7% of that range, 75.6% below the 52-week high.
- That makes 5 straight losses.
Oct 13, 2026 — TOVX ends flat (+0.0%) to $0.22, 4 down days in a row
- Closed at $0.22, +0.00% vs the prior close of $0.22. Day range $0.21–$0.22, opened at $0.22.
- Volume was 358.30K shares, 0.7x its 50-day average of 530.77K.
- Price is -5.9% vs its 50-day average ($0.23) and -8.7% vs its 200-day average ($0.24).
- 52-week range $0.16–$0.86; today's close sits at 9% of that range, 74.4% below the 52-week high.
- That makes 4 straight losses.
Oct 12, 2026 — TOVX ends flat (+0.0%) to $0.22 on 3.2x normal volume
- Closed at $0.22, +0.00% vs the prior close of $0.22. Day range $0.21–$0.24, opened at $0.22.
- Volume was 1.62M shares, 3.2x its 50-day average of 510.28K — unusually heavy trading.
- Price is -5.9% vs its 50-day average ($0.23) and -8.7% vs its 200-day average ($0.24).
- 52-week range $0.16–$0.86; today's close sits at 9% of that range, 74.4% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — TOVX slides 4.3% to $0.22
- Closed at $0.22, -4.35% vs the prior close of $0.23. Day range $0.21–$0.23, opened at $0.23.
- Volume was 485.40K shares, 0.9x its 50-day average of 517.06K.
- Price is -5.8% vs its 50-day average ($0.23) and -8.6% vs its 200-day average ($0.24).
- 52-week range $0.16–$0.86; today's close sits at 9% of that range, 74.4% below the 52-week high.
Oct 8, 2026 — TOVX ends flat (+0.0%) to $0.23
- Closed at $0.23, +0.00% vs the prior close of $0.23. Day range $0.23–$0.24, opened at $0.23.
- Volume was 522.10K shares, 1.0x its 50-day average of 515.76K.
- Price is -1.5% vs its 50-day average ($0.23) and -4.4% vs its 200-day average ($0.24).
- 52-week range $0.16–$0.86; today's close sits at 10% of that range, 73.3% below the 52-week high.
Oct 7, 2026 — TOVX jumps 4.5% to $0.23
- Closed at $0.23, +4.55% vs the prior close of $0.22. Day range $0.22–$0.25, opened at $0.23.
- Volume was 806.00K shares, 1.6x its 50-day average of 507.56K.
- Price is -1.4% vs its 50-day average ($0.23) and -4.3% vs its 200-day average ($0.24).
- 52-week range $0.16–$0.86; today's close sits at 10% of that range, 73.3% below the 52-week high.
Oct 6, 2026 — TOVX slides 4.3% to $0.22, 4 down days in a row
- Closed at $0.22, -4.35% vs the prior close of $0.23. Day range $0.22–$0.24, opened at $0.23.
- Volume was 405.30K shares, 0.8x its 50-day average of 508.87K.
- Price is -5.5% vs its 50-day average ($0.23) and -8.4% vs its 200-day average ($0.24).
- 52-week range $0.16–$0.86; today's close sits at 9% of that range, 74.4% below the 52-week high.
- That makes 4 straight losses.
Oct 5, 2026 — TOVX ends flat (+0.0%) to $0.23, 3 down days in a row
- Closed at $0.23, +0.00% vs the prior close of $0.23. Day range $0.23–$0.24, opened at $0.23.
- Volume was 379.90K shares, 0.7x its 50-day average of 515.42K.
- Price is -1.1% vs its 50-day average ($0.23) and -4.1% vs its 200-day average ($0.24).
- 52-week range $0.16–$0.86; today's close sits at 10% of that range, 73.3% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — TOVX ends flat (+0.0%) to $0.23
- Closed at $0.23, +0.00% vs the prior close of $0.23. Day range $0.23–$0.24, opened at $0.23.
- Volume was 396.40K shares, 0.8x its 50-day average of 520.19K.
- Price is -1.0% vs its 50-day average ($0.23) and -4.1% vs its 200-day average ($0.24).
- 52-week range $0.16–$0.86; today's close sits at 10% of that range, 73.3% below the 52-week high.
TOVX latest news & SEC filings
Every SEC filing by or about TOVX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 9, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Aug 24, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 11, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
:
- Diluted EPS: -$0.07 (prior year -$1.93) (loss narrowed vs Jun 30, 2025)
Aug 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Aug 4, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 5.07 — Reported shareholder vote results.
Jul 7, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Jun 29, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Jun 29, 2026 · Form ARS — Annual report to shareholders
Annual report to shareholders
Things to know before you trade TOVX
- Last results release: Aug 11, 2026 (8-K Item 2.02). Previous ones: May 5, 2026, Mar 12, 2026, Nov 12, 2025. Based on that rhythm, the next report is likely around Nov 10, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.86% (largest 9.5%).
- Liquidity: about 498.40K shares (≈$103.62K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.21 vs a range of $0.16–$0.85 (7% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 10-Q Aug 11, 2026; 8-K Aug 11, 2026; 8-K Aug 6, 2026.
- Share count: 45.89M shares outstanding (Aug 7, 2026), +378.2% vs a year earlier — notable dilution.
- Listing: NYSE · industry: Pharmaceutical Preparations.
TOVX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.22 | 0.22 | 0.21 | 0.21 | 218.00K |
| Oct 15, 2026 | 0.21 | 0.22 | 0.21 | 0.21 | 363.70K |
| Oct 14, 2026 | 0.22 | 0.22 | 0.21 | 0.21 | 382.00K |
| Oct 13, 2026 | 0.22 | 0.22 | 0.21 | 0.22 | 358.30K |
| Oct 12, 2026 | 0.22 | 0.24 | 0.21 | 0.22 | 1.62M |
| Oct 9, 2026 | 0.23 | 0.23 | 0.21 | 0.22 | 485.40K |
| Oct 8, 2026 | 0.23 | 0.24 | 0.23 | 0.23 | 522.10K |
| Oct 7, 2026 | 0.23 | 0.25 | 0.22 | 0.23 | 806.00K |
| Oct 6, 2026 | 0.23 | 0.24 | 0.22 | 0.22 | 405.30K |
| Oct 5, 2026 | 0.23 | 0.24 | 0.23 | 0.23 | 379.90K |
| Oct 2, 2026 | 0.23 | 0.24 | 0.23 | 0.23 | 396.40K |
| Oct 1, 2026 | 0.23 | 0.23 | 0.22 | 0.23 | 427.00K |
| Sep 30, 2026 | 0.22 | 0.23 | 0.22 | 0.23 | 856.00K |
| Sep 29, 2026 | 0.22 | 0.22 | 0.21 | 0.21 | 462.70K |
| Sep 28, 2026 | 0.23 | 0.23 | 0.21 | 0.22 | 754.30K |
| Sep 25, 2026 | 0.22 | 0.24 | 0.22 | 0.22 | 337.50K |
| Sep 24, 2026 | 0.23 | 0.24 | 0.23 | 0.23 | 312.70K |
| Sep 23, 2026 | 0.23 | 0.24 | 0.23 | 0.23 | 324.90K |
| Sep 22, 2026 | 0.23 | 0.24 | 0.23 | 0.23 | 233.30K |
| Sep 21, 2026 | 0.24 | 0.24 | 0.23 | 0.23 | 321.50K |
About Theriva Biologics
Theriva Biologics (TOVX) is listed on the NYSE and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in ROCKVILLE, MD. State of incorporation: NV. Fiscal year ends December 31. SEC CIK 894158.
TOVX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jeffrey J Kraws | Director | Jan 6, 2026 |
| John J Monahan | Director | Jan 6, 2026 |
| Steven A Shallcross | CEO and CFO | Jan 6, 2026 |
| Jeffrey Alan Wolf | Director | Jan 6, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Steven A Shallcross | CEO and CFO | Jan 6, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
TOVX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2023 | — | $-18.35M | -28.48 | $-19.00M |
| Dec 31, 2022 | — | $-19.68M | -1.31 | $-19.08M |
| Dec 31, 2021 | — | $-14.27M | -1.90 | $-12.89M |
| Dec 31, 2020 | — | $-10.04M | — | — |
| Dec 31, 2019 | — | $-15.30M | — | — |
Latest balance sheet: total assets $34.86M, total liabilities $22.67M, cash $11.34M (as of Jun 30, 2026).
TOVX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 11, 2026 | 8-K Item 2.02 (results) | $0.23 |
| May 5, 2026 | 8-K Item 2.02 (results) | $0.38 |
| Mar 12, 2026 | 8-K Item 2.02 (results) | $0.18 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $0.30 |
| Aug 11, 2025 | 8-K Item 2.02 (results) | $0.42 |
| May 14, 2025 | 8-K Item 2.02 (results) | $0.57 |
| Mar 6, 2025 | 8-K Item 2.02 (results) | $1.41 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $1.43 |
| Aug 13, 2024 | 8-K Item 2.02 (results) | — |
| May 7, 2024 | 8-K Item 2.02 (results) | — |
| Mar 25, 2024 | 8-K Item 2.02 (results) | — |
| Nov 13, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on TOVX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.